Helixmith Co., Ltd (KOSDAQ:084990)
South Korea · Delayed Price · Currency is KRW 2,980.00
-20.00 (-0.67%)
Sep 22, 2026, 3:30 PM KST
Helixmith Market Cap
Helixmith has a market cap or net worth of 137.22 billion as of September 22, 2026. Its market cap has decreased by -51.70% in one year.
Market Cap
137.22B
Enterprise Value
83.35B
Revenue
2.42B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,980.00
ChartMarket Cap Chart
Since December 29, 2005, Helixmith's market cap has decreased from 238.64B to 137.22B, a decrease of -42.50%. That is a compound annual growth rate of -2.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 137.22B | -52.09% |
| Dec 30, 2025 | 286.41B | 130.37% |
| Dec 30, 2024 | 124.33B | -51.50% |
| Dec 28, 2023 | 256.37B | -35.45% |
| Dec 29, 2022 | 397.14B | -53.54% |
| Dec 30, 2021 | 854.88B | -3.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bioneer | 227.65B |
| GC Cell | 213.84B |
| NeoImmuneTech | 195.56B |
| HLB Therapeutics | 177.16B |
| GC Genome | 163.19B |
| Anterogen.Co.,Ltd. | 151.49B |
| Genexine | 131.89B |
| Vaxcell-Bio Therapeutics | 101.52B |